Severe airflow obstruction in vertically acquired HIV infection
Gregory L Calligaro1, Aliasgar Esmail1, Diane M Gray2
1Division of Pulmonology, Department of Medicine, Groote Schuur Hospital and UCT Lung Institute, University of Cape Town Cape Town, South Africa.
Human immunodeficiency virus (HIV) and tuberculosis increase chronic airflow limitation risk. HIV-associated lung disease is a growing concern, especially in sub-Saharan Africa, due to complex interactions.
Area of Science:
- Pulmonology
- Infectious Diseases
- Immunology
Background:
- Human immunodeficiency virus (HIV) infection is increasingly recognized as a risk factor for chronic airflow limitation.
- This condition can arise independently or in conjunction with opportunistic infections like pulmonary tuberculosis.
- The multifactorial etiology includes post-infectious obliterative bronchiolitis, post-tuberculous lung damage, immune reconstitution, and direct HIV effects.
Purpose of the Study:
- To highlight the complex interplay between HIV, tuberculosis, and chronic lung disease.
- To underscore the rising significance of HIV-associated chronic lung disease as a cause of pulmonary disability.
- To present a case illustrating these interactions in a high-prevalence region.
Main Methods:
- Case report presentation.
- Review of literature on HIV-associated lung disease and its risk factors.
- Analysis of contributing factors to airflow obstruction in the presented case.
Main Results:
- The case involves a 15-year-old girl with vertically acquired HIV infection.
- She experienced multiple pulmonary infections and severe airflow obstruction.
- The findings illustrate the complex, multifactorial nature of HIV-related chronic lung disease.
Conclusions:
- HIV infection, often with co-existing tuberculosis, significantly contributes to chronic airflow limitation.
- HIV-associated chronic lung disease is an emerging cause of pulmonary disability, particularly in regions with high HIV and TB prevalence.
- Effective management requires understanding the diverse contributing factors to airflow obstruction in this population.
More Related Videos
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
11:14Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
Published on: October 12, 2018
Related Concept Videos
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease II: Emphysema
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
